Felix von Haniel

Felix von Haniel is an accomplished business development leader with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Senior Vice President of Business Development and Marketing at Novalix, Felix orchestrates commercial strategies aimed at enhancing the company's presence in key markets, particularly the UK and US. Prior roles include significant positions at Evotec, Cyprotex, and Ncardia, where extensive expertise in strategic partnerships, revenue growth, and innovative marketing solutions was demonstrated. Additionally, Felix operates as a business angel and investor, supporting various high-impact technology ventures. Felix holds an MBA from the University of Cambridge and degrees in Biotechnology and Molecular Biology from the University of Melbourne.